PROFUND VP EUROPE 30 NVO Holdings History
PROFUND VP EUROPE 30's Novo Nordisk AS Holding Summary
As of 2025-03-31, PROFUNDS held 9,249.00 shares of Novo Nordisk AS(NVO), totaling $642,250.00. This investment constitutes 3.61% of their stock portfolio, and PROFUNDS now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.
The initial trade took place in 2024Q4. And since then PROFUND VP EUROPE 30 has made 2 purchases of NVO, at an average price of $99.30, for a total of 9,249.00 shares. Based on historical transaction data and NVO's current price of $70.03, PROFUND VP EUROPE 30's estimated gain on his NVO holdings is $-270,690.98, reflecting a -29.47% gain to date.
PROFUND VP EUROPE 30 NVO ($70.03) Holding Chart
PROFUND VP EUROPE 30 NVO ($70.03) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
